Abstract
493 Preclinical pharmacokinetic (PK)/pharmacodynamic (PD)/Efficacy modeling for MLN2480, an investigational pan-RAF kinase inhibitor, in A375 and SKMEL-2 human melanoma xenografts
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have